The double dealing of cyclin D1

G Tchakarska, B Sola - Cell cycle, 2020 - Taylor & Francis
The cell cycle is tightly regulated by cyclins and their catalytic moieties, the cyclin-dependent
kinases (CDKs). Cyclin D1, in association with CDK4/6, acts as a mitogenic sensor and …

Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms

A Mafficini, A Scarpa - Endocrine reviews, 2019 - academic.oup.com
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …

Neuroendocrine neoplasms of the small bowel and pancreas

AK Clift, M Kidd, L Bodei, C Toumpanakis… - …, 2020 - karger.com
The traditionally promulgated perspectives of neuroendocrine neoplasms (NEN) as rare,
indolent tumours are blunt and have been outdated for the last 2 decades. Clear increments …

[HTML][HTML] Genetic and epigenetic drivers of neuroendocrine tumours (NET)

A Di Domenico, T Wiedmer, I Marinoni… - Endocrine-related …, 2017 - erc.bioscientifica.com
Neuroendocrine tumours (NET) of the gastrointestinal tract and the lung are a rare and
heterogeneous group of tumours. The molecular characterization and the clinical …

[HTML][HTML] The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours

A Scarpa - Annales d'endocrinologie, 2019 - Elsevier
Abstract Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) arise throughout
the gut and feature varying biological behaviour and malignant potential. GEP-NENs include …

Histone variant H3. 3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeres

M Udugama, FT M. Chang, FL Chan… - Nucleic acids …, 2015 - academic.oup.com
In addition to being a hallmark at active genes, histone variant H3. 3 is deposited by ATRX at
repressive chromatin regions, including the telomeres. It is unclear how H3. 3 promotes …

[HTML][HTML] Gastrinoma

RT Jensen, T Ito - Endotext [Internet], 2023 - ncbi.nlm.nih.gov
Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

[HTML][HTML] Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium

A Mafficini, A Scarpa - Journal of Endocrinology, 2018 - joe.bioscientifica.com
Neuroendocrine tumours (NETs) may arise throughout the body and are a highly
heterogeneous, relatively rare class of neoplasms difficult to study also for the lack of …

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9

UK Ballehaninna, RS Chamberlain - Tumor Biology, 2013 - Springer
Pancreatic adenocarcinoma accounts for nearly 90–95% of exocrine malignant tumors of
the pancreas. Traditionally, overexpressed proteins/epitopes such as CA 19-9, CA-50, CEA …

[HTML][HTML] Biomarkers for pancreatic neuroendocrine neoplasms (PanNENs) management—an updated review

M Bocchini, F Nicolini, S Severi, A Bongiovanni… - Frontiers in …, 2020 - frontiersin.org
Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …